Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Brain-derived neurotrophic factor (BDNF) and its receptor, tropomyosin-related kinase B (TrkB), signaling represent potential therapeutic targets for major depressive disorder. The purpose of this study is to examine whether TrkB ligands show antidepressant effects in an inflammation-induced model of depression. METHODS: In this study, we examined the effects of TrkB agonist 7,8-dihydroxyflavone (7,8-DHF) and TrkB antagonist ANA-12 on depression-like behavior and morphological changes in mice previously exposed to lipopolysaccharide (LPS). Protein levels of BDNF, phospho-TrkB (p-TrkB), and TrkB in the brain regions were also examined. RESULTS: LPS caused a reduction of BDNF in the CA3 and dentate gyrus (DG) of the hippocampus and prefrontal cortex (PFC), whereas LPS increased BDNF in the nucleus accumbens (NAc). Dexamethason suppression tests showed hyperactivity of the hypothalamic-pituitary-adrenal axis in LPS-treated mice. Intraperitoneal (i.p.) administration of 7,8-DHF showed antidepressant effects on LPS-induced depression-like behavior, and i.p. pretreatment with ANA-12 blocked its antidepressant effects. Surprisingly, ANA-12 alone showed antidepressant-like effects on LPS-induced depression-like behavior. Furthermore, bilateral infusion of ANA-12 into the NAc showed antidepressant effects. Moreover, LPS caused a reduction of spine density in the CA3, DG, and PFC, whereas LPS increased spine density in the NAc. Interestingly, 7,8-DHF significantly attenuated LPS-induced reduction of p-TrkB and spine densities in the CA3, DG, and PFC, whereas ANA-12 significantly attenuated LPS-induced increases of p-TrkB and spine density in the NAc. CONCLUSIONS: The results suggest that LPS-induced inflammation may cause depression-like behavior by altering BDNF and spine density in the CA3, DG, PFC, and NAc, which may be involved in the antidepressant effects of 7,8-DHF and ANA-12, respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Blockade of NLRP3 reverses stress-induced increases in IL-1β in the peripheral blood and brain, while also abrogating depressive-like behaviour in mice45.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [45]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“studies in laboratory animals indicate that chronic mild-stress activates the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome, which is well-known to respond to DAMPs44,45.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [45]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,416
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395 · cited 4×
“Peripheral administration of LPS induces sickness behavior that peaks after two to six hours, then gradually wanes (Dantzer et al., 2008).”
BackgroundInfluentialPhysiology and neurobiology of stress and adaptation: central role of the brain
McEwen, B. S. (2007) · Physiological Reviews · doi:10.1152/physrev.00041.2006 · Cited by 5,429 · cited 2×
“Changes in dendritic length and spine density in the hippocampus and PFC are thought to contribute to the neurobiology of MDD, and antidepressant treatment is mediated, in part, by blocking or reversing these changes (McEwen, 2007; Duman and Aghajanian, 2012).”
BackgroundA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 1×
“Meta-analysis shows higher blood levels of pro-inflammatory cytokines in drug-free MDD patients, compared with healthy controls (Dowlati et al., 2010).”
BackgroundThe mouse brain in stereotaxic coordinates
Konsman, J.-P. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00088-x · Cited by 4,045 · cited 4×
“Microinjection needles were placed bilaterally into the NAc shell (+1.7 AP, ±0.75 ML, -3.6 DV) (Paxinos and Watson, 1998).”
MethodInfluentialInflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 1×
“Accumulating evidence suggests that inflammatory processes play a role in the pathophysiology of major depressive disorder (MDD; Dantzer et al., 2008; Hashimoto, 2009; Miller et al., 2009; Raison et al., 2010).”
BackgroundThe Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,566
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 3×
“…signaling to the pathophysiology of MDD, as well as the therapeutic mechanisms of antidepressants (Nestler et al., 2002; Hashimoto et al., 2004; Duman and Monteggia 2006; Martinowich et al., 2007; Hashimoto, 2010; Hashimoto, 2011, 2013a; Duman et al., 2012; Castrén, 2014; Lindholm and…”
BackgroundBardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,219
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · cited 2×
“These findings suggest that both peripheral and central inflammations are associated with depressive symptoms, and it is therefore highly plausible that anti-inflammatory drugs could ameliorate depressive symptoms in these patients.”
BackgroundResultKrishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129 · cited 3×
“Growing evidence reveals a crucial role for the VTA-NAc reward circuits in the neurobiology of depression (Eisch et al., 2003; Berton et al., 2006; Nestler and Carlezon, 2006; Krishnan et al., 2007; Sun et al., 2013).”
BackgroundInfluentialThe mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059 · cited 1×
“26) = 1.359, p = 0.280; NAc: F(4, 25) = 0.716, p = 0.590; Figure 4C).”
InfluentialNMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 2×
“26) = 1.359, p = 0.280; NAc: F(4, 25) = 0.716, p = 0.590; Figure 4C).”
BackgroundInfluentialBrain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654 · cited 3×
“An infusion of BDNF in the DG and CA3, but not the CA1, promoted antidepressant effects in the rat learned helplessness model (Shirayama et al., 2002), and antidepressant treatment attenuated the decrease of BDNF protein in the PFC after LPS administration (Guo et al.”
BackgroundInfluentialSelf-citationSynaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651 · cited 4×
“D and F).”
BackgroundInfluentialAddiction and the brain: The neurobiology of compulsion and its persistence
Hyman, S. E., & Malenka, R. C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094560 · Cited by 1,302 · cited 2×
“26) = 1.359, p = 0.280; NAc: F(4, 25) = 0.716, p = 0.590; Figure 4C).”
BackgroundInfluentialO'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278
New insights into BDNF function in depression and anxiety
Martinowich, K., Manji, H., & Lu, B. (2007) · Nature Neuroscience · doi:10.1038/nn1971 · Cited by 1,221 · cited 3×
“D and F).”
BackgroundRapid regulation of depression-related behaviours by control of midbrain dopamine neurons
Chaudhury, D., Walsh, J. J., Friedman, A. K., Juarez, B., Ku, S. M., Koo, J. W., Ferguson, D., Tsai, H.-C., Pomeranz, L., Christoffel, D. J., et al. (2013) · Nature · doi:10.1038/nature11713 · Cited by 1,156
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 2×
“Accumulating evidence shows that the HPA axis is hyperactive in patients with MDD, and that the DEX suppression test can effectively quantify dysregulation of this axis (Kathol et al., 1989; Pariante and Miller, 2001).”
BackgroundLi, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.015 · Cited by 1,082 · cited 3×
“Recent studies highlight a role for mammalian target of rapamycin complex 1 (mTORC1) signaling in the rapid antidepressant action of the NMDA receptor antagonist ketamine (Li et al., 2010; Li et al., 2011).”
BackgroundMethodResultInfluentialTargeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894 · cited 18×
“The VTA-NAc pathway receives strong glutamatergic inputs from several frontal cortical regions, hippocampus, and amygdala (Hyman and Malenka, 2001; Nestler and Carlezon, 2006; Shirayama and Chaki, 2006; Sanacora et al., 2008).”
BackgroundInfluentialDwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.8.804 · Cited by 875
Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., Agerman, K., Haapasalo, A., Nawa, H., Aloyz, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00349.2003 · Cited by 800 · cited 1×
“, 2004), and responses elicited by antidepressants were lost in mice with either reduced brain BDNF levels or inhibited TrkB signaling (Saarelainen et al., 2003; Monteggia et al., 2007).”
BackgroundA selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
Jang, S.-W., Liu, X., Yepes, M., Shepherd, K. R., Miller, G. W., Liu, Y., Wilson, W. D., Xiao, G., Blanchi, B., Sun, Y. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913572107 · Cited by 686 · cited 1×
“Here, we used 7,8-dihydroxyflavone (7,8-DHF), a novel TrkB agonist (Jang et al., 2010; Andero et al., 2011), and ANA-12, a novel TrkB antagonist (Cazorla et al.”
MethodEssential role of brain-derived neurotrophic factor in adult hippocampal function
Monteggia, L. M., Barrot, M., Powell, C. M., Berton, O., Galanis, V., Gemelli, T., Meuth, S., Nagy, A., Greene, R. W., & Nestler, E. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402141101 · Cited by 685 · cited 1×
“Furthermore, loss of BDNF in the forebrain attenuated the actions of an antidepressant (Monteggia et al., 2004), and responses elicited by antidepressants were lost in mice with either reduced brain BDNF levels or inhibited TrkB signaling (Saarelainen et al.”
BackgroundProtein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines
Tanaka, J.-I., Horiike, Y., Matsuzaki, M., Miyazaki, T., Ellis-Davies, G. C. R., & Kasai, H. (2008) · Science · doi:10.1126/science.1152864 · Cited by 615 · cited 1×
“A two-photon imaging study showed that BDNF and protein synthesis are crucial to the structural plasticity of single dendritic spines (Tanaka et al., 2008), thus linking changes in BDNF levels in the CA3, DG, PFC, and NAc with altered spine density in these regions.”
BackgroundKarege, F., Vaudan, G., Schwald, M., Perroud, N., & La Harpe, R. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.12.020 · Cited by 600 · cited 2×
“Post-mortem data from depressed patients showed that depression is associated with a decrease in BDNF levels in the hippocampus and PFC, and an increase of BDNF in the NAc (Dwivedi et al., 2003; Karege et al., 2005; Krishnan et al., 2007; Sun et al., 2013).”
BackgroundMethodSignaling pathways underlying the rapid antidepressant actions of ketamine
Duman, R. S., Li, N., Liu, R.-J., Duric, V., & Aghajanian, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.044 · Cited by 537 · cited 1×
“5 specific receptor tropomyosin-receptor-kinase B (TrkB), and subsequent mammalian target of rapamycin complex 1 (mTORC1) signaling to the pathophysiology of MDD, as well as the therapeutic mechanisms of antidepressants (Nestler et al., 2002; Hashimoto et al., 2004; Duman and Monteggia 2006; Martinowich et al., 2007;…”
BackgroundCritical Role of Brain-Derived Neurotrophic Factor in Mood Disorders
Hashimoto, K., Shimizu, E., & Iyo, M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.02.003 · Cited by 522 · cited 1×
“26) = 1.359, p = 0.280; NAc: F(4, 25) = 0.716, p = 0.590; Figure 4C).”
InfluentialSelf-citationShelton, R. C., Claiborne, J., Sidoryk-Wegrzynowicz, M., Reddy, R., Aschner, M., Lewis, D. A., & Mirnics, K. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.52 · Cited by 511 · cited 17×
“Considering the emerging role of glutamate in the pathophysiology of MDD (Sanacora et al., 2008; Hashimoto, 2009 2013a, 2013b; Zarate et al., 2010; Krystal et al., 2013), it seems that the glutamatergic systems are integral to the emergence of depression-like behavior after inflammation.”
BackgroundInfluentialMonteggia, L. M., Luikart, B., Barrot, M., Theobold, D., Malkovska, I., Nef, S., Parada, L. F., & Nestler, E. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.021 · Cited by 502 · cited 1×
“, 2004), and responses elicited by antidepressants were lost in mice with either reduced brain BDNF levels or inhibited TrkB signaling (Saarelainen et al., 2003; Monteggia et al., 2007).”
BackgroundEisch, A. J., Bolaños, C. A., de Wit, J., Simonak, R. D., Pudiak, C. M., Barrot, M., Verhaagen, J., & Nestler, E. J. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.003 · Cited by 420 · cited 1×
“26) = 1.359, p = 0.280; NAc: F(4, 25) = 0.716, p = 0.590; Figure 4C).”
InfluentialEpigenetics of the depressed brain: role of histone acetylation and methylation
Sun, H., Kennedy, P. J., & Nestler, E. J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.73 · Cited by 413 · cited 3×
“Thus, it seems that abnormal BDNF levels in the hippocampal, PFC, and VTA-NAc pathways play a causative role in the pathophysiology of MDD, consistent with a recent review (Sun et al., 2013).”
BackgroundResultInfluentialRapid-acting glutamatergic antidepressants: the path to ketamine and beyond
Krystal, J. H., Sanacora, G., & Duman, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.026 · Cited by 406 · cited 2×
“26) = 1.359, p = 0.280; NAc: F(4, 25) = 0.716, p = 0.590; Figure 4C).”
BackgroundInfluentialCazorla, M., Prémont, J., Mann, A., Girard, N., Kellendonk, C., & Rognan, D. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43992 · Cited by 392 · cited 4×
“The doses of 7,8-DHF and ANA-12 were also selected as previously reported (Ren et al., 2013 2014; Cazorla et al., 2011).”
BackgroundMethodInfluentialHashimoto, K. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02113.x · Cited by 388 · cited 4×
“D and F).”
BackgroundMethodInfluentialSelf-citationEmerging role of glutamate in the pathophysiology of major depressive disorder
Hashimoto, K. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.05.005 · Cited by 381 · cited 3×
“Accumulating evidence suggests that inflammatory processes play a role in the pathophysiology of major depressive disorder (MDD; Dantzer et al., 2008; Hashimoto, 2009; Miller et al., 2009; Raison et al., 2010).”
BackgroundInfluentialSelf-citationAdachi, M., Barrot, M., Autry, A. E., Theobald, D., & Monteggia, L. M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.019 · Cited by 380
Govindarajan, A., Rao, B. S. S., Nair, D., Trinh, M., Mawjee, N., Tonegawa, S., & Chattarji, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605180103 · Cited by 333 · cited 2×
“…mice (approximately 50% lower BDNF levels) show a less branched dendritic tree in the CA3 (Magariños et al., 2011) and over-expression of BDNF prevents stress-induced reductions of dendritic branching in the CA3 (Govindarajan et al., 2006), indicating a key role for BDNF in CA3 dendritic spines.”
BackgroundInfluentialRantamäki, T., Hendolin, P., Kankaanpää, A., Mijatovic, J., Piepponen, P., Domenici, E., Chao, M. V., Männistö, P. T., & Castrén, E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301345 · Cited by 305 · cited 1×
“It is also reported that a single dose of SSRIs, such as fluoxetine and citalopram, could rapidly activate TrkB phosphorylation in the brain (Rantamäki et al., 2007).”
BackgroundYu, H., Wang, D.-D., Wang, Y., Liu, T., Lee, F. S., & Chen, Z.-Y. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5048-11.2012 · Cited by 275
Guan, Z., & Fang, J. (2006) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.04.005 · Cited by 247 · cited 2×
“17 but not CA1, after a single dose of LPS, consistent with a previous study (Guan and Fang, 2006).”
ResultMagariños, A. M., Li, C. J., Gal Toth, J., Bath, K. G., Jing, D., Lee, F. S., & McEwen, B. S. (2011) · Hippocampus · doi:10.1002/hipo.20744 · Cited by 232
Glutamatergic Modulators: The Future of Treating Mood Disorders?
Zarate, C., Machado-Vieira, R., Henter, I., Ibrahim, L., Diazgranados, N., & Salvadore, G. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673229.2010.511059 · Cited by 228 · cited 2×
“26) = 1.359, p = 0.280; NAc: F(4, 25) = 0.716, p = 0.590; Figure 4C).”
BackgroundInfluentialEffect of 7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, on Emotional Learning
Andero, R., Heldt, S. A., Ye, K., Liu, X., Armario, A., & Ressler, K. J. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10030326 · Cited by 226 · cited 1×
“Here, we used 7,8-dihydroxyflavone (7,8-DHF), a novel TrkB agonist (Jang et al., 2010; Andero et al., 2011), and ANA-12, a novel TrkB antagonist (Cazorla et al.”
MethodShirayama, Y., & Chaki, S. (2006) · Current Neuropharmacology · doi:10.2174/157015906778520773 · Cited by 225 · cited 2×
“The VTA-NAc pathway receives strong glutamatergic inputs from several frontal cortical regions, hippocampus, and amygdala (Hyman and Malenka, 2001; Nestler and Carlezon, 2006; Shirayama and Chaki, 2006; Sanacora et al., 2008).”
BackgroundSelf-citationStress and CRF gate neural activation of BDNF in the mesolimbic reward pathway
Walsh, J. J., Friedman, A. K., Sun, H., Heller, E. A., Ku, S. M., Juarez, B., Burnham, V. L., Mazei-Robison, M. S., Ferguson, D., Golden, S. A., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3591 · Cited by 210 · cited 3×
“This finding is similar with recent report showing that direct infusion of ANA-12 into NAc completely blocked the ability of phasic stimulation to induce social avoidance (Walsh et al., 2014).”
BackgroundResultInfluentialLiu, X., Chan, C.-B., Jang, S.-W., Pradoldej, S., Huang, J., He, K., Phun, L. H., France, S., Xiao, G., Jia, Y., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101206p · Cited by 208 · cited 1×
“The antidepressant effect of 7,8-DHF is consistent with previous reports showing that 7,8-DHF could promote both neurogenesis in the hippocampus and marked antidepressant effects (Liu et al., 2010 2012).”
ResultOhgi, Y., Futamura, T., Kikuchi, T., & Hashimoto, K. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.003 · Cited by 207 · cited 2×
“, 2010) and antidepressants, including selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs; Ohgi et al., 2013).”
BackgroundSelf-citationHashimoto, K. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.09.001 · Cited by 207
Self-citationClinical role of brain-derived neurotropic factor in mood disorders
Hashimoto, K. (2004) · Medical Entomology and Zoology · Cited by 183
Self-citationRaison, C. L., Lowry, C. A., & Rook, G. A. W. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.161 · Cited by 169 · cited 1×
“Accumulating evidence suggests that inflammatory processes play a role in the pathophysiology of major depressive disorder (MDD; Dantzer et al., 2008; Hashimoto, 2009; Miller et al., 2009; Raison et al., 2010).”
BackgroundNeurotrophins and Psychiatric Disorders
Castrén, E. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-45106-5_17 · Cited by 150 · cited 2×
“…to the pathophysiology of MDD, as well as the therapeutic mechanisms of antidepressants (Nestler et al., 2002; Hashimoto et al., 2004; Duman and Monteggia 2006; Martinowich et al., 2007; Hashimoto, 2010; Hashimoto, 2011, 2013a; Duman et al., 2012; Castrén, 2014; Lindholm and Castrén, 2014).”
BackgroundPathophysiology of HPA axis abnormalities in patients with major depression: an update
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.3.311 · Cited by 123 · cited 18×
“Considering the emerging role of glutamate in the pathophysiology of MDD (Sanacora et al., 2008; Hashimoto, 2009 2013a, 2013b; Zarate et al., 2010; Krystal et al., 2013), it seems that the glutamatergic systems are integral to the emergence of depression-like behavior after inflammation.”
BackgroundInfluentialMice with altered BDNF signaling as models for mood disorders and antidepressant effects
Lindholm, J. S. O., & Castrén, E. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00143 · Cited by 114 · cited 2×
“…to the pathophysiology of MDD, as well as the therapeutic mechanisms of antidepressants (Nestler et al., 2002; Hashimoto et al., 2004; Duman and Monteggia 2006; Martinowich et al., 2007; Hashimoto, 2010; Hashimoto, 2011, 2013a; Duman et al., 2012; Castrén, 2014; Lindholm and Castrén, 2014).”
BackgroundProstaglandins mediate depressive-like behaviour induced by endotoxin in mice
de Paiva, V. N., Lima, S. N. P., Fernandes, M. M., Soncini, R., Andrade, C. A. F., & Giusti-Paiva, A. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.07.015 · Cited by 104
Guo, J., Lin, P., Zhao, X., Zhang, J., Wei, X., Wang, Q., & Wang, C. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.01.008 · Cited by 75 · cited 1×
“, 2002), and antidepressant treatment attenuated decrease of BDNF protein in PFC after LPS administration (Guo et al., 2014), indicating roles for DG, CA3 and PFC, but not CA1, in the antidepressant action of BDNF.”
BackgroundSelf-citationLiu, X., Chan, C.-B., Qi, Q., Xiao, G., Luo, H. R., He, X., & Ye, K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301099x · Cited by 60
Taliaz, D., Nagaraj, V., Haramati, S., Chen, A., & Zangen, A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.07.025 · Cited by 54 · cited 1×
“It has also been reported that the antidepressant-like effect of electroconvulsive therapy in animal models is dependent on reducing BDNF in the VTA, but not on raising hippocampal BDNF expression (Taliaz et al., 2013).”
BackgroundRen, Q., Zhang, J., Ma, M., Fujita, Y., Wu, J., & Hashimoto, K. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3221-7 · Cited by 47
Self-citationRole of the mTOR signaling pathway in the rapid antidepressant action of ketamine
Hashimoto, K. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.176 · Cited by 47 · cited 1×
“…to the pathophysiology of MDD, as well as the therapeutic mechanisms of antidepressants (Nestler et al., 2002; Hashimoto et al., 2004; Duman and Monteggia 2006; Martinowich et al., 2007; Hashimoto, 2010; Hashimoto, 2011, 2013a; Duman et al., 2012; Castrén, 2014; Lindholm and Castrén, 2014).”
BackgroundSelf-citationRen, Q., Zhang, J., Fujita, Y., Ma, M., Wu, J., & Hashimoto, K. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.03.016 · Cited by 39 · cited 1×
“…behavior and alterations in serum pro-inflammatory cytokines induced by LPS can be blocked by anti-inflammatory drugs (de Paiva et al., 2010) and antidepressants, including selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs;…”
BackgroundSelf-citationMorphometric Analysis in Neurodegenerative Disorders
Milatović, D., Montine, T. J., Zaja‐Milatovic, S., Madison, J. L., Bowman, A. B., & Aschner, M. (2010) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx1216s43 · Cited by 33
Lu, R. (2012) · InTech eBooks · doi:10.5772/2268 · Cited by 25
BDNF and proBDNF as biomarkers for bipolar disorder
Hashimoto, K. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.205.5.410 · Cited by 24
Self-citationMorphometric Analysis in Neurodegenerative Disorders
Milatović, D., Montine, T. J., Zaja‐Milatovic, S., Madison, J. L., Bowman, A. B., & Aschner, M. (2010) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx1216s46 · Cited by 23 · cited 1×
“Spines were counted along CA1, CA3, DG, PFC and NAc dendrites starting from their point of origin from the primary dendrite, as previously reported (Milatovic et al., 2010).”
MethodSerum Brain-Derived Neurotrophic Factor as a Predictor of Incident Dementia
Hashimoto, K. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6414 · Cited by 14 · cited 1×
“, blood levels of proBDNF, BDNF) for MDD could prove invaluable in detecting the antidepressant efficacy of TrkB agonists/antagonists (Hashimoto, 2010; Hashimoto, 2014).”
BackgroundSelf-citationTherapeutic implications for NMDA receptors in mood disorders
Hashimoto, K. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811894 · Cited by 10
Self-citation
Cited by
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A. J. O., Bromberg, E., & de Vries, E. F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1283-6 · Cited by 750
BDNF signaling in context: From synaptic regulation to psychiatric disorders
Wang, C. S., Kavalali, E. T., & Monteggia, L. M. (2022) · Cell · doi:10.1016/j.cell.2021.12.003 · Cited by 607
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
Yang, C., Shirayama, Y., Zhang, J.-C., Ren, Q., Yao, W., Ma, M., Dong, C., & Hashimoto, K. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.136 · Cited by 605
Self-citationZhang, J.-C., Yao, W., & Hashimoto, K. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160119094646 · Cited by 538
“We found that similar to ketamine, a single administration of TrkB ligands (7,8-DHF and ANA-12) conferred a rapid antidepressant effect in the social defeat stress model of depression [124].”
InfluentialSelf-citation
Metadata
- Authors
- Zhang, J.-C., Wu, J., Fujita, Y., Yao, W., Ren, Q., Yang, C., Li, S.-X., Shirayama, Y., & Hashimoto, K.
- Affiliations
- Chiba University (JP)
- Corresponding author
- Hashimoto, Kenji
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-01-26
- Volume
- 18
- Issue
- 4
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC4360225
- OpenAlex
- W2055018912
- Cited by
- 289
- References
- 72
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 18 · 2023: 23 · 2022: 26 · 2021: 46 · 2020: 17 · 2019: 24 · 2018: 33 · 2017: 25 · 2016: 37 · 2015: 18
- FWCI
- 27.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Eli Lilly and Company
- Ministry of Education, Culture, Sports, Science and Technology (24116006)
- Astellas Pharma
- Chiba University
- SENSHIN Medical Research Foundation
- Japan Society for the Promotion of Science (24116006)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- TrkB signaling, brain-derived neurotrophic factor, antidepressant effects, depression-like behavior, lipopolysaccharide-induced inflammation, 7,8-dihydroxyflavone, ANA-12, dendritic spine density, hippocampus, prefrontal cortex, nucleus accumbens, hypothalamic-pituitary-adrenal axis, major depressive disorder
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Animals, Antidepressive Agents, Azepines, Benzamides, Depressive Disorder, Disease Models, Animal, Hippocampus, Lipopolysaccharides, Male, Mice, Inbred C57BL, Nucleus Accumbens, Phosphorylation, Prefrontal Cortex, Brain-Derived Neurotrophic Factor, Receptor, trkB, Multiprotein Complexes, Flavones, Dendritic Spines, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.